Shanghai OPM Biosciences Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	979.47	787.45	891.14	1,282	1,506	310.34
Short-Term Investments	30.59	312.53	86.14	52.64	40.07	40.17
Trading Asset Securities	197.61	246.73	358.08	148.75	170.71	-
Cash & Short-Term Investments	1,208	1,347	1,335	1,484	1,717	350.51
Cash Growth	-13.77%	0.85%	-9.99%	-13.57%	389.76%	13.37%
Accounts Receivable	246.28	102.06	110.85	96.35	76.81	41.75
Other Receivables	14.52	3.6	8.57	-	8.04	-
Receivables	260.81	105.66	119.42	96.35	84.85	41.75
Inventory	183.38	73.79	59.12	49.21	44.01	33.72
Prepaid Expenses	-	-	-	-	10.55	-
Other Current Assets	49.03	38.42	35.18	30.17	12.66	15.2
Total Current Assets	1,701	1,565	1,549	1,659	1,869	441.18
Property, Plant & Equipment	468.95	329	376.42	296.92	264.04	142.83
Long-Term Investments	290.25	258.08	264.58	239.73	143.73	68.09
Other Intangible Assets	81.23	35.82	37.68	39.21	40.33	42.46
Long-Term Deferred Tax Assets	21.7	10.47	3.58	2.08	0.84	0.13
Long-Term Deferred Charges	152.04	47.01	52.06	60.3	21.52	25.38
Other Long-Term Assets	443.51	1.65	2.84	4.43	8.53	27
Total Assets	3,742	2,247	2,286	2,302	2,348	747.08

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	57.45	24.09	62.8	37.46	21.31	13.75
Accrued Expenses	26.6	26.31	19.58	18.08	19.91	15.66
Short-Term Debt	-	-	-	-	20.02	40.04
Current Portion of Long-Term Debt	-	-	-	-	4.31	2.13
Current Portion of Leases	121.4	14.92	13.02	8.6	6.45	5.27
Current Income Taxes Payable	8.63	0	4.42	0.62	-	1.63
Current Unearned Revenue	87.53	6.54	15.57	4.28	16.04	16.62
Other Current Liabilities	52.43	5	4.03	1.6	1.21	0.72
Total Current Liabilities	354.04	76.86	119.42	70.65	89.26	95.82
Long-Term Debt	0.14	-	-	-	10.86	17.77
Long-Term Leases	122.91	42.08	52.32	60.79	50.15	56.51
Long-Term Unearned Revenue	27.75	28.42	17.89	12.18	12.54	14.53
Long-Term Deferred Tax Liabilities	11.15	0.94	1.33	0.59	0.26	-
Total Liabilities	599.54	148.29	190.97	144.21	163.07	184.62

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	142.17	113.82	114.77	114.77	81.98	61.49
Additional Paid-In Capital	2,786	1,865	1,904	1,899	1,925	428.34
Retained Earnings	217.05	121.45	128.58	158.74	178	72.63
Treasury Stock	-	-	-51	-13.75	-	-
Comprehensive Income & Other	-3.84	-0.06	0.24	0.19	0.12	-
Total Common Equity	3,141	2,100	2,097	2,159	2,185	562.45
Minority Interest	1.36	-2.15	-1.47	-0.78	-	-
Shareholders' Equity	3,143	2,098	2,095	2,158	2,185	562.45
Total Liabilities & Equity	3,742	2,247	2,286	2,302	2,348	747.08

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	244.45	57	65.34	69.39	91.8	121.72
Net Cash (Debt)	963.22	1,290	1,270	1,414	1,625	228.79
Net Cash Growth	-28.08%	1.55%	-10.20%	-12.96%	610.20%	-16.88%
Net Cash Per Share	4.97	11.44	10.86	12.30	16.04	2.65
Filing Date Shares Outstanding	142.17	113.82	113.55	113.91	114.77	86.08
Total Common Shares Outstanding	142.17	113.82	113.55	114.53	114.77	86.08
Working Capital	1,347	1,488	1,430	1,589	1,780	345.36
Book Value Per Share	22.10	18.45	18.47	18.85	19.03	6.53
Tangible Book Value	2,476	2,065	2,059	2,119	2,144	519.99
Tangible Book Value Per Share	17.42	18.14	18.13	18.51	18.68	6.04
Buildings	226.09	226.09	63.8	63.8	63.8	27.17
Machinery	411.19	239.06	230.6	200.88	128.56	112.33
Construction In Progress	2.78	0.4	169.33	78.1	103.47	1.31